Results 51 to 60 of about 1,137,782 (176)

Update on type 2 cardiorenal syndrome [PDF]

open access: yes, 2015
Department of Internal Medicine, Clinic of Cardiology, Clinic of Rheumatology and Nephrology, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of MoldovaBackground: Cardiorenal syndrome type 2 is an “umbrella” term ...
Sasu, B., Bivol, E., Grib, L.
core   +1 more source

N‐terminal pro‐brain natriuretic peptide and cardiorenal outcome in patients with anaemia in chronic kidney disease

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi   +4 more
wiley   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Analysis of the usefulness and benefits of ultrafiltration in cardiorenal syndrome: A systematic review

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1194-1202, April 2025.
Abstract Aims Cardiac decompensation in cardiorenal syndrome (CRS) results in systemic congestion usually treated with diuretics. When despite high doses of diuretics, response is poor, ultrafiltration (UF) appears to be a useful and safe technique.
Borja Guerrero Cervera   +12 more
wiley   +1 more source

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction

open access: yesЛечащий Врач, 2023
The combination of heart and kidney diseases caused by chronic heart failure and aggravated by kidney damage, called cardiorenal syndrome, is increasingly recognized as a critical pathological unit, leading to a worsening of the prognosis in patients ...
Yu. N. Panina, V. I. Vishnevsky
doaj   +1 more source

Practical Approaches to the Management of Cardiorenal Disease beyond Congestion [PDF]

open access: yes
Background: The coexistence of heart and kidney diseases, also called cardiorenal syndrome, is very common, leads to increased morbidity and mortality, and poses diagnostic and therapeutic difficulties.
Cobo-Marcos, M   +12 more
core   +1 more source

Supplemental material - Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2

open access: yes, 2023
Supplemental material for Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2 by Jianjie Wang, Jianqin Zou, Cheng Zhao, Han Yu, Jiajia Teng and Lei Dong in Human & Experimental Toxicology ...
Lei Dong (165252)   +5 more
core   +1 more source

Serum NT-pro BNP and Other Biochemical Markers in Patients with Cardiorenal Syndrome (CRS) in Thi- Qar province- Iraq [PDF]

open access: yesJournal of Bioscience and Applied Research
"Any chronic or acute problem in the kidneys or heart which can lead to a chronic or acute problem of the other" is known as "cardiorenal syndrome" (CRS).
Hadeel Faraj
doaj   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

The womb as the cradle of longevity: Perinatal origins of biological aging

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract The perinatal period is increasingly recognized as an important determinant of biological aging trajectories and disease susceptibility across the lifespan. This narrative review synthesizes current evidence linking intrauterine exposures to adult health outcomes across three biological dimensions: fetal programming, maternal influences, and ...
Sevim Ozge Ozdemir, Ebru Davutoglu
wiley   +1 more source

Home - About - Disclaimer - Privacy